We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


National Children's Leukemia Foundation Endorses Missouri Stem Cell Research and Cures Initiative

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The National Children's Leukemia Foundation has announced its endorsement of the Missouri Stem Cell Research and Cures Initiative.

The Initiative, a referendum measure slated for the November state ballot, ensures that Missouri patients will have access to any federally approved stem cell cures that are available to other Americans.

"Based on the National Children's Leukemia Foundation's research involvement worldwide, I believe there is no doubt that stem cell therapy will provide the cure," said Steve Shor, Founder and President of the National Children's Leukemia Foundation.

"Only time will reveal the tremendous capacity and far-reaching abilities of this technology."

"However, we can say now that we are very close to a revolution that will enable the medical community to save the lives of hundreds of thousands of people facing life-threatening illness."

The Initiative protects the rights of Missouri patients to have their diseases and injuries treated with cures derived from stem cell research allowed by federal law and available in other states.

It also ensures that Missouri medical institutions and research facilities can provide and help find stem cell cures.

And, it establishes clear ethical and oversight guidelines for stem cell research conducted in Missouri - including a strict ban on any attempt to clone a human being.